PCV15 SWITCHING VS. CONTINUING APIXABAN TREATMENT IS ASSOCIATED WITH A GREATER RISK FOR MAJOR BLEEDING-RELATED HOSPITALIZATION IN ELDERLY PATIENTS WITH NVAF
May 1, 2019, 00:00
10.1016/j.jval.2019.04.451
https://www.valueinhealthjournal.com/article/S1098-3015(19)30643-6/fulltext
Title :
PCV15 SWITCHING VS. CONTINUING APIXABAN TREATMENT IS ASSOCIATED WITH A GREATER RISK FOR MAJOR BLEEDING-RELATED HOSPITALIZATION IN ELDERLY PATIENTS WITH NVAF
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30643-6&doi=10.1016/j.jval.2019.04.451
First page :
Section Title :
Open access? :
No
Section Order :
10091